The promotional effort from Ferring features bladder cancer survivors sharing the news of a new treatment option.
Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the ...
BMO Capital analysts view the departure of Dr. Peter Marks from the FDA as a “significant negative” for the biopharma and biotech sectors. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback